MX2021015553A - Inhibidores de arginasa novedosos. - Google Patents
Inhibidores de arginasa novedosos.Info
- Publication number
- MX2021015553A MX2021015553A MX2021015553A MX2021015553A MX2021015553A MX 2021015553 A MX2021015553 A MX 2021015553A MX 2021015553 A MX2021015553 A MX 2021015553A MX 2021015553 A MX2021015553 A MX 2021015553A MX 2021015553 A MX2021015553 A MX 2021015553A
- Authority
- MX
- Mexico
- Prior art keywords
- novel
- arginase inhibitors
- novel arginase
- inhibitors
- arginase
- Prior art date
Links
- 102000004452 Arginase Human genes 0.000 title abstract 3
- 108700024123 Arginases Proteins 0.000 title abstract 3
- 239000003112 inhibitor Substances 0.000 title abstract 2
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 abstract 2
- 206010039085 Rhinitis allergic Diseases 0.000 abstract 1
- 201000010105 allergic rhinitis Diseases 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/025—Boronic and borinic acid compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/69—Boron compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pulmonology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente invención se relaciona con inhibidores de arginasa novedosos de fórmula (I). Esos compuestos novedosos son útiles en el tratamiento de enfermedades que están asociadas con la actividad arginasa, como el asma, rinitis alérgica y EPOC (enfermedad pulmonar obstructiva crónica).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP19180260 | 2019-06-14 | ||
PCT/EP2020/066507 WO2020249821A1 (en) | 2019-06-14 | 2020-06-15 | Novel arginase inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2021015553A true MX2021015553A (es) | 2022-02-16 |
Family
ID=66867016
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2021015553A MX2021015553A (es) | 2019-06-14 | 2020-06-15 | Inhibidores de arginasa novedosos. |
Country Status (8)
Country | Link |
---|---|
US (1) | US11845767B2 (es) |
EP (1) | EP3983068B1 (es) |
JP (1) | JP2022536168A (es) |
KR (1) | KR20220024051A (es) |
AU (1) | AU2020293645A1 (es) |
CA (1) | CA3142859A1 (es) |
MX (1) | MX2021015553A (es) |
WO (1) | WO2020249821A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW202228720A (zh) | 2020-12-22 | 2022-08-01 | 波蘭商昂科艾倫迪治療法股份公司 | 精胺酸酶抑制劑及其使用方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL410665A1 (pl) | 2014-12-29 | 2016-07-04 | Oncoarendi Therapeutics Spółka Z Ograniczoną Odpowiedzialnością | Inhibitory arginazy oraz ich zastosowania terapeutyczne |
-
2020
- 2020-06-15 WO PCT/EP2020/066507 patent/WO2020249821A1/en active Application Filing
- 2020-06-15 US US17/617,065 patent/US11845767B2/en active Active
- 2020-06-15 AU AU2020293645A patent/AU2020293645A1/en not_active Abandoned
- 2020-06-15 EP EP20731511.0A patent/EP3983068B1/en active Active
- 2020-06-15 JP JP2021573458A patent/JP2022536168A/ja active Pending
- 2020-06-15 CA CA3142859A patent/CA3142859A1/en active Pending
- 2020-06-15 MX MX2021015553A patent/MX2021015553A/es unknown
- 2020-06-15 KR KR1020217041043A patent/KR20220024051A/ko unknown
Also Published As
Publication number | Publication date |
---|---|
EP3983068B1 (en) | 2024-03-20 |
CA3142859A1 (en) | 2020-12-17 |
EP3983068C0 (en) | 2024-03-20 |
JP2022536168A (ja) | 2022-08-12 |
WO2020249821A1 (en) | 2020-12-17 |
KR20220024051A (ko) | 2022-03-03 |
US11845767B2 (en) | 2023-12-19 |
AU2020293645A1 (en) | 2021-12-23 |
EP3983068A1 (en) | 2022-04-20 |
US20220227791A1 (en) | 2022-07-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201991793A1 (ru) | ПРОИЗВОДНЫЕ ТИРОЗИНАМИДА В КАЧЕСТВЕ ИНГИБИТОРОВ Rho-КИНАЗЫ | |
CY1123391T1 (el) | (2s)-n-[(1s)-1-kyano-2-φainyλaιθyλ]-1,4-oξazeπan-2-καρβοξαμιδια ως αναστολεις της διπεπτιδυλικης πεπτιδασης ι | |
MX2019005526A (es) | Derivados biciclicos de dihidropirimidina-carboxamida como inhibidores de rho-cinasa. | |
EA201990019A1 (ru) | Соединения и композиции для подавления активности shp2 | |
EA201490730A1 (ru) | 1-пиразолил-3-(4-((2-анилинопиримидин-4-ил)окси)нафталин-1-ил)мочевины как ингибиторы p38 map-киназы | |
PH12015502563B1 (en) | Bipyrazole derivatives as jak inhibitors | |
EA201691401A1 (ru) | Индазольные соединения в качестве ингибиторов irak4 | |
JOP20200286A1 (ar) | بنزاميدات مستبدلة بـ 1 ، 3-ثيازول-2-يل للمعالجة من أمراض مصاحبة لتحسس الألياف العصبية | |
EA201891143A1 (ru) | Пиперидиноновые агонисты формилпептидного рецептора 2 и формилпептидного рецептора 1 | |
EA201790908A1 (ru) | Новые производные тиенопиримидина в качестве ингибиторов nik | |
MX2021000270A (es) | Derivados de la tirosina amida como inhibidores de la rho- cinasa. | |
MX2021015553A (es) | Inhibidores de arginasa novedosos. | |
EA201070917A1 (ru) | Двойные фармакофоры - pde4-мускариновые антагонисты | |
TR201905319T4 (tr) | Nevralji, ağrı, KOAH (Kronik, Obstruktif Akciğer Hastalığı) ve astım tedavisinde TRPM8-inhibitörleri olarak yararlı 2-aril-4-hidroksi-1,3-tiyazol türevleri. | |
MX2021014116A (es) | Derivados de piridopirimidinas como inhibidores del purinoreceptor 3 de p2x (p2x3). | |
EA201270265A1 (ru) | Ингибиторы катепсина с | |
TR201716199A1 (tr) | Arformoterol ve ipratropium içeren yeni farmasötik bileşimler. | |
TR201716209A2 (tr) | Arformoterol ve umeklidinyum içeren yeni farmasötik bileşimler. | |
MX2016001747A (es) | Derivados de difeniloxialquilamina y derivados de ariloxialquilamina, composicion farmaceutica, uso de dicha composicion farmaceutica para tratar, prevenir o inhibir enfermedades inflamatorias pulmonares cronicas y metodo para tratar o prevenir dichas enfermedades. | |
MX2023005867A (es) | Derivados de dihidrofuropiridina como inhibidores de la cinasa rho. | |
MX2023005866A (es) | Derivados de dihidrofuropiridina como inhibidores de rho-cinasa. | |
MX2023005865A (es) | Derivados de dihidrofuropiridina como inhibidores de rho-cinasa. | |
UA110978C2 (uk) | Азетидинілфенілові, піридилові або піразинілкарбоксамідні похідні як інгібітори jak | |
JO3130B1 (ar) | يوريات 1-بيرازوليل-3- (4 - ((2-أنيلينو بيريميدين-4-ايل) أوكسي) نفثالين-1-ايل) بصفتها مثبطات نوع بي 38 ماب كينيز |